update

NYSE Content advisory: Pre-Market update + Investors Digest Nvidia’s Latest Earnings

NEW YORK, Aug. 28, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

8 months ago

NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia’s earnings

NEW YORK, Aug. 27, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

8 months ago

NYSE Content Advisory: Pre-Market Update + Investors Monitoring Latest Fed, Earnings Developments

NEW YORK, Aug. 26, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

8 months ago

NYSE Content Advisory: Pre-Market update + Fed Chair Jerome Powell Set to Deliver Jackson Hole Speech

NEW YORK, Aug. 22, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

9 months ago

NYSE Content Advisory: Pre-Market Update + ESPN celebrates streaming service launch

NEW YORK, Aug. 21, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

9 months ago

NYSE Content Advisory: Pre-Market Update + NYSE Texas to celebrate launch at AT&T Stadium

NEW YORK, Aug. 20, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

9 months ago

NYSE Content Advisory: Pre-Market Update + Retail Earnings Kick Off

NEW YORK, Aug. 19, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

9 months ago

MedX Holdings, Inc. (OTC: MEDH) Med X Holdings Q2 2025 Investor Update: Were at an Inflection Point

Austin, Texas, Aug. 19, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MedX Holdings, Inc. (OTC: MEDH) Med-X Holdings Q2 2025…

9 months ago

NYSE Content Advisory: Pre-Market Update + ‘Taking Stock’ Series launches before Closing Bell

NEW YORK, Aug. 18, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

9 months ago

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

    - Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial - Expanded global IP protection by securing…

9 months ago